CERS vs CL · rev $201.3M vs P/E 34, rev $20.38B
Cerus Corporation (CERS) versus Colgate-Palmolive Company (CL) — a side-by-side from cached financials, not a winner call.
Cerus Corporation (CERS) is a medical devices company listed on US.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Latest reported CERS revenue for 2024-12-31 was $201.3M. Net income was -$21.0M. Revenue was up 7.8% from 2023-12-31 to 2024-12-31. CERS currently screens at market cap $294.4M.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
CERS currently screens at market cap $294.4M. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Not investment advice. Open the CERS and CL stock pages for the full models.
Not investment advice.